Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cefuroxime (1.5gm)
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
VIAL+ WATER
Packaging
Mono
Price
₹355/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cefuzrom 1.5 Injection is a sterile formulation containing cefuroxime, a broad-spectrum cephalosporin antibiotic effective against a variety of bacterial infections. This medication works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. It is commonly indicated for the treatment of respiratory tract infections, skin and soft tissue infections, urinary tract infections, and certain types of meningitis. Its efficacy against both gram-positive and gram-negative bacteria makes it a versatile choice in the management of infections.
Cefuzrom 1.5 Injection is typically administered intravenously or intramuscularly, depending on the clinical scenario and physician's recommendation. The dosage and duration of treatment depend on the severity of the infection, the patient's overall health status, and the specific pathogens involved. As with any antibiotic therapy, it's crucial to complete the full course of treatment to reduce the risk of developing antibiotic-resistant bacteria.
Possible side effects include allergic reactions, gastrointestinal disturbances, and localized pain at the injection site.
Cefuzrom 1.5 Injection is indicated for bacterial infections such as respiratory, urinary, and skin infections.
Cefuzrom 1.5 Injection should only be used under medical supervision and is contraindicated in patients with known allergies to cephalosporins or penicillins. When using Cefuzrom 1.5 Injection, healthcare professionals must monitor patients for potential adverse reactions and adjust dosages as necessary. This medication may interact with other drugs; therefore, informing the healthcare provider of all medications being taken is essential. Additionally, it is important to consider renal function in patients receiving this treatment, as dosage adjustments may be required for those with impaired kidney function. In summary, Cefuzrom 1.5 Injection serves as an essential option for effectively managing a variety of bacterial infections, provided it is used appropriately under medical guidance.
Store in a cool, dry place away from direct sunlight.
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
Composition : Clarithromycin (500mg) Injection
Composition : Clindamycin (300mg) Injection
Composition : Clindamycin (600mg)
Composition : Colistimethate Sodium (1Million IU)
Composition : Colistimethate Sodium (2Million IU)
Composition : Doxycycline (100mg) + Vitamin C (100mg)
Composition : Meropenem (1000mg) Injection
Composition : Meropenem (1000mg) + Sulbactam (500mg)
Composition : Meropenem (250mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cefuroxime 1.5gm Injection has strong demand in the hospital, anti-infective, surgical care, and critical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on injectable antibiotics and institutional healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for bacterial infection management under medical supervision. Cefuroxime 1.5gm is a second-generation cephalosporin antibiotic with broad-spectrum antibacterial activity Commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, gynecological infections, and surgical prophylaxis Widely used in hospitals, nursing homes, surgical units, and emergency care settings Injectable formulation ensures rapid therapeutic action and effective infection control This strengthens a comprehensive anti-infective and hospital-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Cefuroxime 1.5gm Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital demand, institutional procurement opportunities, repeat orders, reliable supply chain support, high market acceptance, and attractive margins in the injectable antibiotic segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.